UK’s Real-World Evidence Expectations Still Not Clear To Industry
Medtech companies looking to gain reimbursement for digital products in the UK are hindered by a confusing funding system and unclear real-world evidence requirements, but improvements should be easy to implement, trade association ABHI says.
You may also be interested in...
UK policymakers will need to walk a fine line when developing regulation for AI as a medical device. An independent expert review sets out the need for carefully balanced rules that support innovation without allowing unsafe products to enter the market.
Shortages of medical devices ranging from insulin pumps to robotic surgical systems are impacting clinicians across the EU, leaving many healthcare providers without effective alternative products, a report by the Biomedical Alliance in Europe shows.
Steps are being taken in the EU to address shortages of critical medical devices as a result of regulatory pressures, including those for use in children and for rare conditions, the European Commission’s Stella Kyriakides stated during a recent debate.